Centaurus Biotech

When it goes for pathogen detection and accurate diagnostic, Centaurus Biotech has developed an ultra-sensitive detection solution to see what others can’t!

  • Stage Product In Development
  • Industry Biotechnology
  • Location Manassas, VA, USA
  • Currency USD
  • Founded January 2017
  • Employees 4
  • Incorporation Type LLC
  • Website centaurusbiotech.com

Company Summary

Centaurus Biotech propose a next generation diagnostic platform for pathogen detection and rapid response.
This novel, patented sample preparation platform is agnostic to any detection system, provides an ultra-sensitive pathogen detection based on the unique characteristic of a scavenger protein that capture all pathogen types.
It is fast, accurate, avoid false positives, and eliminates interfering substances from complex biological samples.

Team

  • Chief Operating Office

    Dr. Gonzalez (M.D., Ph.D.) as COO and co-founder leads all company aspects. He directed worldwide medical science research teams from Institutes and University based structures (Dakar and Bangui Pasteur Institutes; Vaccine Center, Bangkok; Yale Arbovirus Research, USA; Emerging Research Disease Unit, Res. Inst. for Development, Paris). He worked as an expert with National (Europe, Africa, Asia) and International Health Authorities (WHO, FAO).

  • Venkat Rao
    Chief Executive Officer

    Dr. Rao is the Company Executive Director, Affiliate Faculty, School of Systems Biology at George Mason University, member of the American Board of Toxicology, Washington D.C. Metro Area. He is a nationally known expert in the fields of biomedical toxicology, pharmacology, and toxics-informatics. He direct collaborative research projects in biological defense technologies and systems with GMU, Parsons, and agencies.

  • Francisco VEAS
    Chief Strategy and Science Officer

    Dr. Veas, CSO and Co-founder, holds oversight on all prospective developments and experimental studies. FHe received a Comparative Pathology Doctorate from the Montpellier University. Dr. Veas is an expert evaluator of Excellence Research Programs in Infectious Diseases by the NIH (USA), WHO, the French National Research Agency (ANR), the IRD Commission of Biology; the French Business-Supporting Agency OSEO, theEuropean Commission, among others.

Advisors

  • Tom Monath
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free